ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - roxithromycin, quantity: 150 mg - tablet, film coated - excipient ingredients: povidone; sodium starch glycollate type a; glucose; purified talc; hypromellose; maize starch; sodium starch glycollate type b; propylene glycol; hyprolose; poloxamer; titanium dioxide; colloidal anhydrous silica; magnesium stearate - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. nongonococcal urethritis. children: roxithromycin 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible microorganisms: acute pharyngitis. acute tonsillitis, impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: hyprolose; povidone; propylene glycol; purified talc; sodium starch glycollate type a; hypromellose; sodium starch glycollate type b; maize starch; magnesium stearate; colloidal anhydrous silica; poloxamer; glucose; titanium dioxide - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. nongonococcal urethritis. appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - fexofenadine hydrochloride, quantity: 30 mg - tablet, film coated - excipient ingredients: titanium dioxide; pregelatinised maize starch; hypromellose; macrogol 400; colloidal anhydrous silica; magnesium stearate; povidone; microcrystalline cellulose; croscarmellose sodium; iron oxide red; iron oxide yellow - relief of symptoms associated with seasonal allergic rhinitis, allergic rhinitis or urticaria in adults and children from 6 years of age.

कनाडा - अंग्रेज़ी - Health Canada

hoechst marion roussel canada inc. - terfenadine - tablet - 120mg - terfenadine 120mg - second generation antihistamines

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - pseudoephedrine 120mg;  ; terfenadine 60mg - tablet - active: pseudoephedrine 120mg   terfenadine 60mg excipient: calcium carbonate colloidal silicon dioxide hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry clear ys-1-7006 opadry white ys-1r-7003 polysorbate 80 pregelatinised maize starch purified water sodium laurilsulfate sodium starch glycolate zinc stearate

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - terfenadine 60mg - tablet - 60 mg - active: terfenadine 60mg excipient: gelatin lactose monohydrate magnesium stearate maize starch sodium bicarbonate

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - terfenadine 120mg - tablet - 120 mg - active: terfenadine 120mg excipient: gelatin lactose monohydrate magnesium stearate maize starch pregelatinised maize starch purified water sodium bicarbonate

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

abbvie pte. ltd. - lopinavir; ritonavir - tablet, film coated - 100mg - lopinavir 100mg; ritonavir 25mg

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

abbvie pte. ltd. - lopinavir; ritonavir - tablet, film coated - 200.0mg - lopinavir 200.0mg; ritonavir 50.0mg

कनाडा - अंग्रेज़ी - Health Canada

merrell pharms inc., division of merrell dow (can) - terfenadine - tablet - 60mg - terfenadine 60mg - second generation antihistamines